Cargando…
OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease
PURPOSE: Approximately 228,820 people are diagnosed annually with lung cancer diagnosis and 135,720 die from their disease(1). EGFR and KRAS targeted therapies have been shown to significantly improve treatment of non-small cell lung cancer (NSCLC), but they don’t apply to the majority of patients....
Autores principales: | Kazarian, Marina, Cui, Jin, Tocino, Irena, Mahajan, Amit, Aboian, Mariam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351181/ http://dx.doi.org/10.1093/noajnl/vdab071.066 |
Ejemplares similares
-
OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
por: Brim, Waverly Rose, et al.
Publicado: (2021) -
OTHR-15. Assessment of TRIPOD adherence in articles developing machine learning models for differentiation of glioma from brain metastasis
por: Jekel, Leon, et al.
Publicado: (2021) -
OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors
por: Shah, Khalid, et al.
Publicado: (2021) -
OTHR-05. Diagnosis and Treatment of Solitary Pituitary Metastatic Cancer: A Case Series
por: Shan, Changguo, et al.
Publicado: (2021) -
OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment
por: Grogan, Nicole, et al.
Publicado: (2021)